Indications

• Calan 40mg (HCI) is primarily indicated in conditions like Angina, Cardiac arrhythmia, Hypertension, ischaemic heart disease, Paroxysmaltachyarrhythmias, Supraventricular arrhythmias, Supraventricular tachycardia, and can also be given in adjunctive therapy as an alternative drug of choice in Cardiomyopathy, Migraine Psychosis, Pulmonary hypertension

Contraindication

• Calan 40mg (HCI) is contraindicated in conditions like Heart failure,Bradycardia Platelet dysfunction.

Side Effects

• The severe or irreversible adverse effects of Calan 40mg (HCI), which give rise to further complications include Hepatotoxicity, Impotence, Mental confusion, Hyperprolactinemia, Myoclonic dystonia Calan 40mg (HCI) produces potentially life-threatening effects which include Cardiac arrhythmias, Heart failure, which are responsible for the discontinuation of Calan 40mg (HCI) therapy. The signs and symptoms that are produced after the acute overdosage of Calan 40mg (HCN) include Bradycardia, Hypotension, AV block. The symptomatic adverse reactions produced by Calan 40mg (HCI) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Palpitation, Constipation, Flushing

Warnings

• Calan 40mg should be used with caution in patients with liver or kidney impairment. Consider decrease in dose of calcium channel blockers and monitor drug response in cirrhosis patients.